Allergan Reports Fourth Quarter and Full-Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Allergen (AGN) PT Raised to $203 at RBC Capital
February 10, 2020 11:45 AM ESTRBC Capital analyst Randall Stanicky raised the price target on Allergen (NYSE: AGN) to $203.00 (from $197.00) while maintaining a Sector Perform rating.
Strong 4Q results provide encouraging read- through to ABBV/AGN proforma outlook... MoreAllergan (AGN) Tops Q4 EPS by 65c
February 10, 2020 7:03 AM ESTAllergan (NYSE: AGN) reported Q4 EPS of $5.22, $0.65 better than the analyst estimate of $4.57. Revenue for the quarter came in at $4.35 billion versus the consensus estimate of $4.09 billion.
For earnings history and earnings-related data on Allergan (AGN) click here.
... More